Market research
CLXT Calyxt Inc
NASDAQ USD Consumer Cyclical
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 31M
- P/E ratio
- Not available
- Analyst target
- 7.25
- Dividend yield
- 0.0%
- Beta
- 2.04
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Consumer Cyclical
- Industry
- Specialty Retailers
- ISIN
- Not available
- Market cap
- 31M
- P/E ratio
- Not available
- Analyst target
- 7.25
- Dividend yield
- 0.0%
- Beta
- 2.04
About
About Calyxt Inc
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Research context
Calyxt Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Consumer Cyclical
- Industry
- Specialty Retailers
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CLXT discussion.
5 years, 6 months ago
Calyxt, Inc is currently in a long term downtrend where the price is trading 21.7% below its 200 day moving average.
From a valuation standpoint, the stock is 95.0% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 8.9.
Calyxt, Inc's total revenue rose by 270.1% to $14M since the same quarter in the previous year.
Its net income has dropped by 10.1% to $-13M since the same quarter in the previous year.
Finally, its free cash flow fell by 73.0% to $-13M since the same quarter in the previous year.
Based on the above factors, Calyxt, Inc gets an overall score of 2/5.